EMA Submission Support: Market Size & Forecast 2026

The global EMA Submission Support market sits at approximately USD 12.5 billion in 2025 (base year), held in a structurally tight balance between accelerating biologics and biosimilar filing volumes, a mandated transition to eCTD v4.0 format that launched on 19 March 2026, and chronic under-prediction of submission timelines that has kept consulting demand persistently above plan. The category spans regulatory strategy consulting, CTD/eCTD dossier preparation, biostatistics and programming, CMC support, and quality documentation services for marketing authorisation applications, variations, clinical trial applications, and paediatric investigation plans filed with the European Medicines Agency. > **Analyst Take.** The call is to lock dual-source agreements now, before eCTD v4.0 compliance costs hit Q3-Q4 2026 budgets. Vendors with validated v4.0 pipelines will command a 10-15% premium by

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.